NASDAQ •
Healthcare •
Medical Devices •
Quote as of 07/08/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization996.78 mln
Float60.31 mln
Earnings Date08/17/2026
Beneish M-Score
-3.92
Highly reliable
1-Year Forecast
15.33
Exceptional upside
Relative Strength
19
/ 100
Significantly lagging
Debt / Equity
0.01
Debt-free
ROE
-136
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Anteris Technologies Global Corp. is an Australian medical device company focused on treating heart valve disease through minimally invasive procedures. Its flagship product, the DurAVR system, uses a catheter to deliver an artificial aortic valve designed to closely replicate how a healthy human valve functions. The company also develops tissue preparation technology that reduces calcium buildup in animal-derived materials used for heart surgery, along with a precision delivery tool that helps surgeons navigate the catheter safely through the heart.
